Red blood cell components: Time to revisit the sources of variability

Blood Transfusion

Volumn 15, Issue 2, 2017, Pages 116-125

  Sparrow, Rosemary L ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Blood donor; Component processing; Red blood cells; Transfusion

Indexed keywords

ALCOHOL CONSUMPTION; BLOOD COMPONENT; BLOOD DONOR; BLOOD SAMPLING; DIABETES MELLITUS; DIETARY INTAKE; DONOR SELECTION; ERYTHROCYTE; ERYTHROCYTE PRESERVATION; ERYTHROCYTE TRANSFUSION; GENETIC DISORDER; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INFLAMMATION; LIFESTYLE; OBESITY; OXIDATIVE STRESS; PHYSICAL ACTIVITY; QUALITY CONTROL; REVIEW; SCREENING; SMOKING; BLOOD STORAGE; OXIDATION REDUCTION REACTION; PROCEDURES;

BLOOD DONORS; BLOOD PRESERVATION; ERYTHROCYTE TRANSFUSION; ERYTHROCYTES; HUMANS; OXIDATION-REDUCTION;

EID: 85014995139     PISSN: 17232007     EISSN: None     Source Type: Journal    
DOI: 10.2450/2017.0326-16     Document Type: Review

References (103)

1. Klein HG. Blood donor demographics and transfusion recipient survival - no country for old men? JAMA Intern Med 2016; 176: 1315-6.
2. Hess JR. Red cell changes during storage. Transfus Apher Sci 2010; 43: 51-9.
3. Sparrow RL. Red blood cell storage and transfusion-related immunomodulation. Blood Transfus 2010; 8: s26-30.
4. D'Alessandro A, Kriebardis AG, Rinalducci S, et al. An update on red blood cell storage lesions, as gleaned through biochemistry and omics technologies. Transfusion 2015; 55: 205-19.
5. Chen D, Serrano K, Devine DV. Introducing the red cell storage lesion. ISBT Science Series 2016; 11: 26-33.
6. Lacroix J, Hobert PC, Fergusson DA, et al. ABLE Investigators; Canadian Critical Care Trials Group. Age of transfused blood in critically ill adults. N Engl J Med 2015; 372: 1410-8.
7. Steiner ME, Ness PM, Assmann SF, et al. Effects of red-cell storage duration on patients undergoing cardiac surgery. N Engl J Med 2015; 372: 1419-29.
8. Heddle NM, Cook RJ, Arnold DM, et al. Effect of short-term vs long-term blood storage on mortality after transfusion. N Engl J Med 2016; 375: 1937-45.
9. Alexander PE, Barty R, Fei Y, et al. Transfusion of fresher vs older red blood cells in hospitalized patients: a systematic review and meta-analysis. Blood 2016; 127: 400-10.
10. Remy KE, Sun J, Wang D, et al. Transfusion of recently donated (fresh) red blood cells (RBCs) does not improve survival in comparison with current practice, while safety of the oldest stored units is yet to be established: a meta-analysis. Vox Sang 2016; 111: 43-54.
11. Wang D, Sun J, Solomon SB, et al. Transfusion of older stored blood and risk of death:a meta-analysis. Transfusion 2012; 52:1184-95.
12. Dern RJ, Gwinn RP, Wiorkowski JJ. Studies on the preservation of human blood. I. Variability in erythrocyte storage characteristics among healthy donors. J Lab Clin Med 1966; 67: 955-65.
13. Dumont LJ, AuBuchon JP. Evaluation of proposed FDA criteria for the evaluation of radiolabeled red cell recovery trials. Transfusion 2008; 48: 1053-60.
14. Hess JR, Sparrow RL, van der Meer PF, et al. Red blood cell hemolysis during blood bank storage: using national quality management data to answer basic scientific questions. Transfusion 2009; 49: 2599-2603.
15. McAteer MJ, Dumont LJ, Cancelas J, et al. Multi-institutional randomised control study of haemolysis in stored red cell units prepared manually or by an automated system. Vox Sang 2010; 99: 34-43.
16. Jordan A, Chen D, Yi QL, et al. Assessing the influence of component processing and donor characteristics on quality of red cell concentrates using quality control data. Vox Sang 2016; 111: 8-15.
17. Kanias T, Sinchar D, Osei-Hwedieh D, et al. Testosteronedependent sex differences in red blood cell hemolysis in storage, stress, and disease. Transfusion 2016; 56: 2571-83.
18. van 't Erve TJ, Wagner BA, Martin SM, et al. The heritability of hemolysis in stored human red blood cells. Transfusion 2015; 55: 1178-85
19. Tzounakas VL, Kriebardis AG, Papassideri IS, Antonelou MH. Donor-variation effect on red blood cell storage lesion: a close relationship emerges. Proteomics Clin Appl 2016; 10: 791-804.
20. Klein HG. Should blood be an essential medicine? N Engl J Med 2013; 368: 199-201.
21. Slopecki A, Smith K, Moore S. The value of Good Manufacturing Practice to a Blood Service in managing the delivery of quality. Vox Sang 2007; 92: 187-96.
22. Greening DW, Glenister KM, Sparrow RL, Simpson RJ. International blood collection and storage: clinical use of blood products. J Proteomics 2010; 73: 386-95.
23. Eder A, Goldman M, Rossmann S, et al. Selection criteria to protect the blood donor in North America and Europe: past (dogma), present (evidence), and future (hemovigilance). Transfu Med Rev 2009; 23: 205-20.
24. Goldman M, Magnussen K, Gorlin J, et al. International forum regarding practices relating to donor haemoglobin and iron. Vox Sang 2016; 111: 449-55.
25. Vuk T, Magnussen K, de Kort W, et al. International forum: an investigation of iron status in blood donors. Blood Transfus 2017; 15: 20-41.
26. Agnihotri N, Pal L, Thakur M, Kumar P. The need to label red blood cell units with their haemoglobin content: a single centre study on haemoglobin variation due to donor-related factors. Blood Transfus 2014; 12: 520-6.
27. Hess JR. Scientific problems in the regulation of red blood cell products. Transfusion 2012; 52: 1827-35.
28. Hess JR; for the BEST Collaborative. Measures of stored red blood cell quality. Vox Sang 2014; 107: 1-19.
29. van der Meer PF, de Korte D. The effect of holding times of whole blood and its components during processing on in vitro and in vivo quality. Transfus Med Rev 2015; 29: 24-34.
30. Hansen AL, Kurach JDR, Turner TR, et al. The effect of processing method on the in vitro characteristics of red blood cell products. Vox Sang 2015; 108: 350-8.
31. Radwanski K, Garraud O, Cognasse F, et al. The effects of red blood cell preparation method on in vitro markers of red blood cell aging and inflammatory response. Transfusion 2013; 53: 3128-38.
32. Heddle NM, Arnold DM, Acker JP, et al. Red blood cell processing method and in-hospital mortality: a transfusion registry cohort study. Lancet Haematol 2016; 3: e246-54.
33. Chasse M, McIntyre L, English SW, et al. Effect of blood donor characteristics on transfusion outcomes: a systematic review and meta-analysis. Transfus Med Rev 2016; 30: 69-80.
34. Raval JS, Waters JH, Seltsam A, et al. Menopausal status affects the susceptibility of stored RBCs to mechanical stress. Vox Sang 2011; 100: 418-21.
35. Chasse M, Tinmouth A, English SW, et al. Association of blood donor age and sex with recipient survival after red blood cell transfusion. JAMA Intern Med 2016; 176: 1307-14.
36. Vasan SK, Chiesa F, Rostgaard K, et al. Lack of association between blood donor age and survival of transfused patients. Blood 2016; 127: 658-61.
37. Desmarets M, Bardiaux L, Benzenine E, et al. Effect of storage time and donor sex of transfused red blood cells on 1-year survival in patients undergoing cardiac surgery: an observational study. Transfusion 2016; 56: 1213-22.
38. Bjursten H, Dardashti A, Bjirk J, et al. Transfusion of sexmismatched and non-leukocyte-depleted red blood cells in cardiac surgery increases mortality. J Thorac Cardivasc Surg 2016; 152: 223-32.
39. Middelburg RA, Briet E, van der Bom JG. Mortality after transfusions, relation to donor sex. Vox Sang 2011; 101: 221-9.
40. Suzman R, Beard J. Global Health and Aging. World Health Organization; 2011. Available at: http://www.who.int/ageing/publications/global-health/en/. Accessed on 24/10/2016.
41. Sayers M, Centilli J. The aging of the donor base. Transfusion 2012; 52: 2717-22.
42. World Health Organization. Global status report on noncommunicable diseases; 2014. Available at: http://www.who.int/nmh/publications/ncd-status-report-2014/en/. Accessed on 24/10/2016.
43. Organisation for Economic Co-operation and Development. OECD Obesity update; 2014. Available at: http://www.oecd.org/health/obesity-update.htm. Accessed on 16/03/2015.
44. Aguilar M, Bhuket T, Torres S, et al. Prevalence of the metabolic syndrome in the United States, 2003-2012. JAMA 2014; 313: 1973-4.
45. O'Neill S, O'Driscoll L. Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies. Obesity Rev 2015; 16: 1-12.
46. Cameron AJ, Magliano DJ, Zimmet PZ, et al. The metabolic syndrome in Australia: prevalence using four definitions. Diabetes Res Clin Pract 2007; 77: 471-8.
47. Radosinska J, Vrbjar N. The role of red blood cell deformability and Na,K-ATPase function in selected risks of cardiovascular disease in humans: focus on hypertension, diabetes mellitus and hypercholesterolemia. Physiol Res 2016; 65: S43-54.
48. Spanidis Y, Mpesios A, Stagos D, et al. Assessment of the redox status in patients with metabolic syndrome and type 2 diabetes reveals great variations. Exp Ther Med 2016; 11: 895-903.
49. Guiraudou M, Varlet-Marie E, Raynaud de Mauverger E, Brun JF. Obesity-related increase in whole blood viscosity includes different profiles according to fat localization. Clin Hemorheol Microcirc 2013; 55: 63-73.
50. Zeng NF, Mancuso JE, Zivkovic AM, et al. Red blood cells from individuals with abdominal obesity or metabolic abnormalities exhibit less deformability upon entering a constriction. PLos One 2016; 11: e0156070.
51. Winker TW, Justice AE, Graff M, et al. The influence of age and sex on genetic associations with adult body size and shape: a large-scale genome-wide interaction study. PLoS Genet 2015; 11: e1005378.
52. Lu Y, Day FR, Gustafsson S, et al. New loci for body fat percentage reveal link between adiposity and cardiometabolic disease risk. Nat Commun 2016; 7: 10495.
53. Cornelis MC, Kacprowski T, Menni C, et al. Genome-wide association study of caffeine metabolites provides new insights to caffeine metabolism and dietary caffeine-consumption behavior. Hum Mol Genet 2016; DOI: 10.1093/hmg/ddw334.
54. Shungin D, Winkler TW, Croteau-Chonka DC, et al. New genetic loci link adipose and insulin biology to body fat distribution. Nature 2015; 518: 187-96.
55. Locke AE, Kahali B, Berndt SI, et al. Genetic studies of body mass index yield new insights for obesity biology. Nature 2015; 518: 197-206.
56. Chaleckis R, Murakami I, Takada J, et al. Individual variability in human blood metabolites identifies age-related differences. Proc Natl Acad Sci USA 2016; 113: 4252-9.
57. Weisenhorn EM, Van't Erve TJ, Riley NM, et al. Multi-omics evidence for inheritance of energy pathways in red blood cells. Mol Cell Proteomics 2016; 15: 3614-23.
58. Liu B, Taioli E. Seasonal variations of complete blood count and inflammatory biomarkers in the US population - analysis of NHANES data. PLoS One 2015; 10: e0142382.
59. Bashir S, Wiltshire M, Cardigan R, et al. Lipaemic plasma induces haemolysis in resuspended red cell concentrate. Vox Sang 2013; 104: 218-24.
60. Cassera MB, Silber AM, Gennaro AM. Differential effects of cholesterol on acyl chain order in erythrocyte membranes as a function of depth form the surface. An electron paramagnetic resonance (EPR) spin label study. Biophys Chem 2002; 99: 117-27.
61. Herreras Z, Cofin M, Catalan M, et al. The proportion of total C18:1 trans-fatty acids in red blood cell membranes relates to carotid plaque prevalence. J Nutr Biochem 2016; 38: 81-5.
62. Vassallo RR, Stearns FM. Lipemic plasma: a renaissance. Transfusion 2011; 51: 1136-9.
63. Peffer K, de Kort WL, Slot E, et al. Turbid plasma donations in whole blood donors. Fat chance? Transfusion 2011; 51: 1179-87.
64. Fu X, Felcyn JR, Odem-Davis K, Zimring JC. Bioactive lipids accumulate in stored red blood cells despite leukoreduction: a targeted metabolomics study. Transfusion 2016; 56: 2560-70.
65. Unruh D, Srinivasan R, Benson T, et al. Red blood cell dysfunction induced by high-fat diet: potential implications for obesity-related atherosclerosis. Circulation 2015; 132: 1898-908.
66. Rink SM, Mendola P, Mumford SL, et al. Self-report of fruit and vegetable intake that meets the 5 a day recommendation is associated with reduced levels of oxidative stress biomarkers and increased levels of antioxidant defense in premenopausal women. J Acad Nutr Diet 2013; 113: 776-85.
67. Wang Y, Yang M, Lee SG, et al. Dietary total antioxidant capacity is associated with diet and plasma antioxidant status in healthy young adults. J Acad Nutr Diet 2012; 112: 1626-35.
68. Ludwig IA, Clifford MN, Lean ME, et al. Coffee: biochemistry and potential impact on health. Food Funt 2014; 5: 1695-717.
69. Grinberg LN, Newmark H, Kitrossky N, et al. Protective effects of tea polyphenols against oxidative damage to red blood cells. Biochem Pharmacol 1997; 54: 973-8.
70. Gostner JM, Becker K, Ueberall F, Fuchs D. The good and bad of antioxidant foods: An immunological perspective. Food Chem Toxicol 2015; 80: 72-9.
71. Julia V, Macia L, Dombowicz D. The impact of diet on asthma and allergic diseases. Nat Rev Immunol 2015; 15: 308-22.
72. Toth A, Sandor B, Pappi J, et al. Moderate red wine consumption improves hemorheological parameters in healthy volunteers. Clin Hemorheol Microcirc 2014; 56: 13-23.
73. Rabai M, Detterich JA, Wenby RB, et al. Effects of ethanol on red blood cell rheological behavior. Clin Hemorheol Microcirc 2014; 56: 87-99.
74. Marotta F, Safran P, Tajiri H, et al. Improvement of hemorheological abnormalities in alcoholics by an oral antioxidant. Hepatogastroenterology 2001; 48: 511-7.
75. Maturu P, Vaddi DR, Pannuru P, Nallanchakravarthula V. Modification of erythrocyte membrane proteins, enzymes and transport mechanisms in chronic alcoholics: an in vivo and in vitro study. Alcohol Alcohol 2013; 48: 679-86.
76. Emans ME, Gaillard CA, Pfister R, et al. Red cell distribution width is associated with physical inactivity and heart failure, independent of established risk factors, inflammation or iron metabolism; the EPIC-Norfolk study. Int J Cardiol 2013; 168: 3550-5.
77. Pingitore A, Lima GP, Mastorci F, et al. Exercise and oxidative stress: potential effects of antioxidant dietary strategies in sports. Nutrition 2015; 31: 916-22.
78. Brinkmann C, Brixius K. Peroxiredoxins and sports: new insights on the antioxidative defense. J Physiol Sci 2013; 63: 1-5.
79. Azizbeigi K, Azarbayjani MA, Peeri M, et al. The effect of progressive resistance training on oxidative stress and antioxidant enzyme activity in erythrocytes in untrained men. Int J Sport Nutr Exerc Metab 2013; 23: 230-8.
80. Pretorius E, du Plooy JN, Soma P, et al. Smoking and fluidity of erythrocyte membranes: a high resolution scanning electron and atomic force microscopy investigation. Nitric Oxide 2013; 35: 42-6.
81. Ergun DD, Karis D, Alkan FA, et al. Effects of cigarette smoking on hemorheologic parameters, plasma osmolality and lung function. Clin Hemorheol Microcirc 2016; 63: 313-324
82. Hakim IA, Harris R, Garland L, et al. Gender difference in systemic oxidative stress and antioxidant capacity in current and former heavy smokers. Cancer Epidemiol Biomarkers Prev 2012; 21: 2193-200.
83. Bloomer RJ, Fisher-Wellman K. The role of exercise in minimizing postprandial oxidative stress in cigarette smokers. Nicotine Tob Res 2009; 11: 3-11.
84. Schwarz V, Bachelier K, Schirmer SH, et al. Red wine prevents the acute negative vascular effects of smoking. Am J Med 2017; 130: 95-100.
85. Mittag D, Sran A, Chan KS, et al. Stored red blood cell susceptibility to in vitro transfusion-associated stress conditions is higher after longer storage and increased by storage in saline-adenine-glucose-mannitol compared to AS-1. Transfusion 2015; 55: 2197-206.
86. Fleming RE, Ponka P. Iron overload in human disease. N Engl J Med 2012; 366: 348-59.
87. Pietrangelo A. Genetics, genetic testing, and management of hemochromatosis: 15 years since hepcidin. Gastroenterology 2015; 149: 1240-51.
88. Creighton Mitchell T, McClain DA. Diabetes and hemochromatosis. Curr Diab Rep 2014; 14: 488.
89. Pankow J, Boerwinkle E, Adams PC, et al. HFE C282Y homozygotes have reduced low-density lipoprotein cholesterol: the Atherosclerosis Risk in Communities (ARIC) Study. Transl Res 2008; 152: 3-10.
90. Luten M, Roerdinkholder-Stoelwinder B, Rombout-Sestrienkova E, et al. Red cell concentrates of hemochromatosis patients comply with the storage guidelines for transfusion purposes. Transfusion 2008; 48: 436-41.
91. Sut C, Hamzeh-Cognasse H, Laradi S, et al. Properties of donated red blood cell components from patients with hereditary hemochromatosis. Transfusion 2017; 57: 166-77.
92. Naik RP, Haywood C Jr. Sickle cell trait diagnosis: clinical and social implications. Hematol Am Soc Hematol Educ Program 2015; 2015: 160-7
93. Ojodu J, Hulihan MM, Pope SN, Grant AM. Incidence of sickle cell trait - United States, 2010. MMWR 2014; 63: 1155-8.
94. Gibson JS, Rees DC. How benign is sickle cell trait? EBiomed 2016; 11: 21-2.
95. Schuetz AN, Hillyer KL, Roback JD, Hillyer CD. Leukoreduction filtration of blood with sickle cell trait. Transfus Med Rev 2004; 18: 168-76.
96. Amar KO, Bourdonn? O, Bruneau S, et al. Assessment of leucoreduction of sickle cell trait blood:quality of the filtered product. Blood Transfus 2014; 12: s193-8.
97. Osei-Hwedieh DO, Kanias T, St Croix C, et al. Sickle cell trait increases red blood cell storage hemolysis and posttransfusion clearance in mice. EBiomed 2016; 11: 239-48.
98. Williams TN, Weatherall DJ. World distribution, population genetics, and health burden of the hemoglobinopathies. Cold Spring Harb Perspect Med 2012; 2: a011692.
99. Luzzatto L, Nannelli C, Notaro R. Glucose-6-phosphate dehydrogenase deficiency. Hematol Oncol Clin North Am 2016; 30: 373-93.
100. Francis RO, Jhang JS, Pham HP et al. Glucose-6-phosphate dehydrogenase deficiency in transfusion medicine: the unknown risks. Vox Sang 2013; 105: 271-82.
101. Renzaho AM, Husser E, Polonsky M. Should blood donors be routinely screened for glucose-6-phosphate dehydrogenase deficiency? A systematic review of clinical studies focusing on patients transfused with glucose-6-phosphate dehydrogenase-deficient red cells. Transfus Med Rev 2014; 28: 7-17.
102. Tzounakas VL, Kriebardis AG, Georgatzakou HT, et al. Glucose 6-phosphate dehydrogenase deficient subjects may be better "storers" than donors of red blood cells. Free Radic Biol Med 2016; 96: 152-65.
103. Kleinman S, Busch MP, Murphy EL, et al. The National Heart, Lung, and Blood Institute Recipient Epidemiology and Donor Evaluation Study (REDS-III): a research program striving to improve blood donor and transfusion recipient outcomes. Transfusion 2014; 54: 942-55.